総説

英語

2025年刊行

1. Walied A. Kamel, Jayaraman Krishnaraj and Rieko Ohki. The Role of PHLDA3 in Cancer Progression and Its Potential as a Therapeutic Target. Cancers, 17(7), 1069, March 2025.

2024年刊行

1. Die Hu, Naoya Kobayashi and Rieko Ohki. FUCA1: An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression. Cancers, 16 (15), 2753; https://doi.org/10.3390/cancers16152753, August 2024.

2023年刊行

1. Jayaraman Krishnaraj, Tatsuki Yamamoto and Rieko Ohki. p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment. Cancers, 15(13), 3399, June 2023.

2020年刊行

1. Yu Chen and Rieko Ohki. p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis. Int. J. Mol. Sci., 21(11), 4098, 2020.

2019年刊行

1. Tatsuya Kawase, Yu Chen, Rieko Ohki.  IER5 Is a p53-Regulated Activator of HSF1 That Contributes to Promotion of Cancer.  Heat Shock Proteins in Signaling Pathways, Chapter 13, Heat Shock Proteins, Vol. 17, pp. 253-272, 2019.

2017年刊行

1. Masahiro Takikawa and Rieko Ohki (corresponding author).
   A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors.
   Cancer Science, 108(6):1101-1108, 2017.

1999年刊行

1. Rieko Ohki and Fuyuki Ishikawa. Telomerase in cancer and senescence.
 Molecular Medicine, vol. 36, pp. 1316-1323, 1999.

1997年刊行

1. Rieko Ohki and Nobuyuki Tanaka. IRF-1 as a regulator of cell cycle, proliferation and oncogenesis. Experimental Medicine, vol. 15, pp. 1956-1961, 1997.

1995年刊行

1. Ryoiti Kiyama, Shinichi Inoue, Rieko Ohki, Eriko Kikuya, Hiroshi Yokota and Michio Oishi.
A differential cloning procedure for rearranged or altered genomic DNA based on in-gel competitive reassociation. Advances in Biophysics, vol. 31, pp. 151-161, 1995.